INTI insider transaction filings
Inhibitor Therapeutics, Inc. — 17 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-04. Screen INTI transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 6 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
Recent Form 4 filings — Inhibitor Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Black Robe Capital LLC — 10% owner MCNULTY JAMES A — Chief Financial Officer | Gift (G): 3,200,000 @ $0 | EDGAR |
| 2026-08-04 | 4 | OSMAN RONALD E — Director, 10% owner Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 — 10% owner | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-08-04 | 4 | Yanez Michelle — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-08-04 | 4 | SEARS SAMUEL P JR — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-08-04 | 4 | ODONNELL FRANCIS E JR — Chief Executive Officer, Director, 10% owner | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-06-24 | 4 | Jerman Michael Allen — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-06-01 | 4 | Vasisht Niraj — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-04-10 | 4 | Vasisht Niraj — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-04-07 | 4 | Jerman Michael Allen — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-04-07 | 4 | Yanez Michelle — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-04-07 | 4 | SEARS SAMUEL P JR — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-04-07 | 4 | OSMAN RONALD E — Director, 10% owner Ronald E Osman Irrevocable Trust III — 10% owner | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-05-16 | 4 | SEARS SAMUEL P JR — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-05-16 | 4 | OSMAN RONALD E — Director, 10% owner Ronald E Osman Irrevocable Trust III — 10% owner | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-05-16 | 4 | Yanez Michelle — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-05-16 | 4 | Jerman Michael Allen — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-05-16 | 4 | MCNULTY JAMES A — CHIEF FINANCIAL OFFICER, 10% owner | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Inhibitor Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-01 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=INTI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →